Pill that mimics Viagra can slow Alzheimer's progression, study suggests
Reported bythe Guardian ↗·Sourced by Goodlede
In a stage three trial spanning 13 countries, the tablet AR1001 slowed cognitive decline by 31% in patients with early Alzheimer's disease not receiving other treatments.
This is a stage three trial result. The drug did not achieve statistically significant results in a wider group of patients already taking other Alzheimer's medications.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at the Guardian
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
General
Seaweed earplug among grant-winning Design Museum prototypes
Dezeen · Verified
Health
Scientists developed 'smart floss' that uses gunk between teeth to track metabolism
ScienceAlert · Verified
David vs Goliath
Borneo Indigenous groups turn land rights victory into warning for future generations
Mongabay · Verified